|

Trastuzumab Deruxtecan in Advanced Breast Cancer

RECRUITINGSponsored by Wenjin Yin
Actively Recruiting
SponsorWenjin Yin
Started2025-08-28
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07180264

Summary

To evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged ≥18 and older
* Breast cancer patients meeting current guideline recommendations and planning to receive trastuzumab deruxtecan
* ECOG 0-1

Exclusion Criteria:

* During pregnancy and lactation

Conditions3

Advanced Breast CancerBreast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.